• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Coronavirus

Therapy to reduce men’s testosterone seen as promising coronavirus treatment

By
Naomi Kresge
Naomi Kresge
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Naomi Kresge
Naomi Kresge
and
Bloomberg
Bloomberg
Down Arrow Button Icon
May 7, 2020, 1:38 AM ET

Therapy to reduce testosterone and other hormones in men with prostate cancer may have a protective effect against the new coronavirus, a study of thousands of Italian patients showed.

Men with the disease who got hormone therapy had a fourfold lower risk of virus infection than patients who didn’t get such treatment, the study showed. The difference was even more pronounced when the research team compared prostate cancer patients on hormone therapy with people who had any other type of cancer.

The results don’t mean that virus patients should start taking hormone therapy, cautioned Fabrice Andre, director of research at the Institut Gustave Roussy in Paris and editor-in-chief of Annals of Oncology, where the results were published. But the data show that it would be worth studying the therapy in infected people, Andre said.

“This is really a new piece in the puzzle,” said Andrea Alimonti, a professor of oncology at the Universita della Svizzera Italiana and ETH Zurich in Switzerland. Researchers are preparing a follow-up study in which high-risk virus patients would be randomly assigned to take the hormone treatment, and plan to be ready to start if there’s a second wave of infections later this year, Alimonti said.

Reducing testosterone might help because a receptor for male hormones also regulates a protein called TMPRSS2, shown in other research to help Covid-19 infect healthy cells. Therapies that suppress male hormones can also decrease TMPRSS2 — not just in the prostate, but in other tissues in the body, Alimonti said.

The study looked at 4,532 men infected with Covid-19 in Italy’s Veneto region, finding that about 10% had cancer, while 2.6% had prostate cancer. Cancer patients had nearly twice the risk of getting the virus compared with the male population as a whole, and got sicker once they were infected. However, among the 5,273 men on hormone therapy for prostate cancer in Veneto, just four got the coronavirus, and none died.

One confounding factor could have been that cancer patients on hormone therapy are treated at home instead of going to a hospital, making them better able to stick to social distancing, Alimonti said.

More coronavirus coverage from Fortune:

—The Rebuild Program: A project to help small businesses reopen amid a pandemic
—The pandemic makes the case for more transparent layoffs
—Reopening of Shanghai Disneyland is a proving ground for pandemic-era theme parks
—Photo essay: What life looks like in Europe as the continent starts to reopen
—Goldman Sachs doubts there will be a Round 3 of PPP loans for small businesses
—Most college students won’t get stimulus checks—but they should
—How the film industry is planning its post-pandemic return
—PODCAST: How Marc Benioff is helping out during the coronavirus pandemic
—WATCH: Fortune’s top 10 heroes of the coronavirus pandemic

Subscribe to How To Reopen, Fortune’s weekly newsletter on what it takes to reboot business in the midst of a pandemic

About the Authors
By Naomi Kresge
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
0

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
24 hours ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
20 hours ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
19 hours ago
placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
3 days ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
15 hours ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
13 hours ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.